| Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere− serum interface: implications for stealth nanoparticle engineering I Hamad, O Al-Hanbali, AC Hunter, KJ Rutt, TL Andresen, SM Moghimi ACS nano 4 (11), 6629-6638, 2010 | 304 | 2010 |
| Synthesis, characterization, and applications of metal nanoparticles AJ Shnoudeh, I Hamad, RW Abdo, L Qadumii, AY Jaber, HS Surchi, ... Biomaterials and bionanotechnology, 527-612, 2019 | 300 | 2019 |
| Poly (ethylene glycol) s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process I Hamad, AC Hunter, J Szebeni, SM Moghimi Molecular immunology 46 (2), 225-232, 2008 | 290 | 2008 |
| Methylation of the phosphate oxygen moiety of phospholipid‐methoxy (polyethylene glycol) conjugate prevents PEGylated liposome‐mediated complement activation and anaphylatoxin … S Moein Moghimi, I Hamad, TL Andresen, K Jørgensen, J Szebeni, ... The FASEB journal 20 (14), 2591-2593, 2006 | 228 | 2006 |
| Complement activation cascade triggered by PEG–PL engineered nanomedicines and carbon nanotubes: The challenges ahead SM Moghimi, AJ Andersen, SH Hashemi, B Lettiero, D Ahmadvand, ... Journal of controlled release 146 (2), 175-181, 2010 | 189 | 2010 |
| Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover I Hamad, AC Hunter, KJ Rutt, Z Liu, H Dai, SM Moghimi Molecular immunology 45 (14), 3797-3803, 2008 | 144 | 2008 |
| Modified-chitosan nanoparticles: Novel drug delivery systems improve oral bioavailability of doxorubicin A Khdair, I Hamad, H Alkhatib, Y Bustanji, M Mohammad, R Tayem, ... European Journal of Pharmaceutical Sciences 93, 38-44, 2016 | 95 | 2016 |
| Liposome-mediated triggering of complement cascade SM Moghimi, I Hamad Journal of liposome research 18 (3), 195-209, 2008 | 83 | 2008 |
| Activation of the human complement system by cholesterol-rich and pegylated liposomes—modulation of cholesterol-rich liposome-mediated complement activation by elevated serum … S Moein Moghimi, I Hamad, R Bünger, TL Andresen, K Jørgensen, ... Journal of liposome research 16 (3), 167-174, 2006 | 75 | 2006 |
| Complement monitoring of Pluronic 127 gel and micelles: suppression of copolymer-mediated complement activation by elevated serum levels of HDL, LDL, and apolipoproteins AI and … I Hamad, AC Hunter, SM Moghimi Journal of controlled release 170 (2), 167-174, 2013 | 46 | 2013 |
| Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug I Hamad, SM Moghimi Expert opinion on drug delivery 5 (2), 205-219, 2008 | 46 | 2008 |
| Nanoemulsion-based film formulation for transdermal delivery of carvedilol AZ Alkilani, R Hamed, S Al-Marabeh, A Kamal, R Abu-Huwaij, I Hamad Journal of Drug Delivery Science and Technology 46, 122-128, 2018 | 42 | 2018 |
| Chitosan nanoparticles as a novel drug delivery system: a review article SM Matalqah, K Aiedeh, NM Mhaidat, KH Alzoubi, Y Bustanji, I Hamad Current drug targets 21 (15), 1613-1624, 2020 | 35 | 2020 |
| Novel in vitro and in vivo anti-Helicobacter pylori effects of pomegranate peel ethanol extract A Mayyas, M Abu-Sini, R Amr, RT Akasheh, W Zalloum, A Khdair, ... Veterinary World 14 (1), 120, 2021 | 20 | 2021 |
| In vitro artificial membrane-natural mucosa correlation of carvedilol buccal delivery A Khdair, I Hamad, M Al-Hussaini, D Albayati, H Alkhatib, B Alkhalidi Journal of Drug Delivery Science and Technology 23 (6), 603-609, 2013 | 19 | 2013 |
| Efficacy of serratiopeptidase after impacted third molar surgery: a randomized controlled clinical trial Z Tamimi, R Al Habashneh, I Hamad, M Al-Ghazawi, AA Roqa’a, ... BMC oral health 21, 1-9, 2021 | 17 | 2021 |
| Factors controlling pharmacokinetics of intravenously injected nanoparticulate systems SM Moghimi, I Hamad Nanotechnology in drug delivery, 267-282, 2009 | 16 | 2009 |
| Green synthesis of gold, iron and selenium nanoparticles using phytoconstituents: Preliminary evaluation of antioxidant and biocompatibility potential AJ Shnoudeh, L Qadumii, M Zihlif, HJ Al-Ameer, RA Salou, AY Jaber, ... Molecules 27 (4), 1334, 2022 | 13 | 2022 |
| Evaluation of immunomodulatory effects of lamotrigine in BALB/c mice EY Abu-Rish, SY Elhayek, YS Mohamed, I Hamad, Y Bustanji Acta Pharmaceutica 67 (4), 543-555, 2017 | 12 | 2017 |
| Microfluidic nanomaterial synthesis and in situ SAXS, WAXS, or SANS characterization: manipulation of size characteristics and online elucidation of dynamic structural transitions A Yaghmur, I Hamad Molecules 27 (14), 4602, 2022 | 10 | 2022 |
